Obaid Afzal
About
Obaid Afzal is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science.
According to data from OpenAlex, Obaid Afzal has authored 187 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 38 papers in Organic Chemistry and 34 papers in Pharmaceutical Science. Recurrent topics in Obaid Afzal's work include Synthesis and biological activity (26 papers), Advanced Drug Delivery Systems (21 papers) and Nanoparticle-Based Drug Delivery (15 papers). Obaid Afzal is often cited by papers focused on Synthesis and biological activity (26 papers), Advanced Drug Delivery Systems (21 papers) and Nanoparticle-Based Drug Delivery (15 papers). Obaid Afzal collaborates with scholars based in Saudi Arabia, India and Australia. Obaid Afzal's co-authors include Abdulmalik Saleh Alfawaz Altamimi, Imran Kazmi, Waleed Hassan Almalki, Sandhya Bawa, Sami I. Alzarea, Md Rahmat Ali, Manu Jaggi, Rajiv Kumar, Md Rafi Haider and Suresh Kumar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
In The Last Decade
Obaid Afzal
174 papers receiving 4.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Obaid Afzal Saudi Arabia | 37 | 1.7k | 1.1k | 659 | 506 | 443 | 187 | 4.4k | ||
| Abdulmalik Saleh Alfawaz Altamimi Saudi Arabia | 32 | 1.4k 0.8× | 360 0.3× | 608 0.9× | 418 0.8× | 431 1.0× | 165 | 3.3k | ||
| V.G.M. Naidu India | 45 | 2.3k 1.4× | 1.5k 1.5× | 311 0.5× | 424 0.8× | 287 0.6× | 146 | 5.8k | ||
| Chung Yeng Looi Malaysia | 38 | 2.2k 1.3× | 683 0.6× | 547 0.8× | 290 0.6× | 416 0.9× | 111 | 6.0k | ||
| Keshav Raj Paudel Australia | 37 | 1.7k 1.0× | 375 0.4× | 331 0.5× | 413 0.8× | 459 1.0× | 206 | 4.7k | ||
| Kulbhushan Tikoo India | 39 | 1.7k 1.0× | 462 0.4× | 276 0.4× | 389 0.8× | 349 0.8× | 188 | 5.0k | ||
| Tânia Beatriz Creczynski‐Pasa Brazil | 35 | 1.3k 0.8× | 613 0.6× | 229 0.3× | 397 0.8× | 393 0.9× | 134 | 3.8k | ||
| Imran Kazmi Saudi Arabia | 42 | 2.5k 1.5× | 300 0.3× | 1.2k 1.8× | 546 1.1× | 503 1.1× | 296 | 6.3k | ||
| Sami I. Alzarea Saudi Arabia | 35 | 1.7k 1.0× | 292 0.3× | 993 1.5× | 321 0.6× | 282 0.6× | 199 | 4.1k | ||
| István Zupkó Hungary | 38 | 2.3k 1.3× | 1.4k 1.3× | 348 0.5× | 277 0.5× | 282 0.6× | 265 | 4.9k | ||
| Saikat Dewanjee India | 42 | 2.3k 1.3× | 375 0.4× | 389 0.6× | 448 0.9× | 473 1.1× | 141 | 6.1k |
Countries citing papers authored by Obaid Afzal
Since
Specialization
Citations
This map shows the geographic impact of Obaid Afzal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Obaid Afzal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Obaid Afzal more than expected).
Fields of papers citing papers by Obaid Afzal
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Obaid Afzal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Obaid Afzal. The network helps show where Obaid Afzal may publish in the future.
Co-authorship network of co-authors of Obaid Afzal
This figure shows the co-authorship network connecting the top 25 collaborators of Obaid Afzal. A scholar is included among the top collaborators of Obaid Afzal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Obaid Afzal. Obaid Afzal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kharshoum, Rasha M., et al.. (2025). Optimized delivery of Enalapril Maleate via polymeric Invasomal in-situ gel for glaucoma treatment: In vitro, in vivo, and histological studies. Journal of Drug Delivery Science and Technology. 106. 106685–106685.
2.
Ali, Khaled, et al.. (2024). Ocular mucoadhesive and biodegradable spanlastics loaded cationic spongy insert for enhancing and sustaining the anti-inflammatory effect of prednisolone Na phosphate; Preparation, I-optimal optimization, and In-vivo evaluation. International Journal of Pharmaceutics X. 8. 100293–100293.
3.
Bhat, Asif Ahmad, Obaid Afzal, Neetu Agrawal, et al.. (2023). A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-κB signaling in inflammatory lung diseases. International Journal of Biological Macromolecules. 253(Pt 4). 126951–126951.
4.
Beg, Sarwar, Obaid Afzal, Imran Kazmi, et al.. (2023). Natural microbial surfactant containing self-nanoemulsifying formulation with improved performance of paclitaxel therapy: A newer avenue in breast cancer treatment. Journal of Drug Delivery Science and Technology. 90. 105105–105105.
5.
Sharma, Arun Kumar, et al.. (2023). Investigating miRNA subfamilies: Can they assist in the early diagnosis of acute myocardial infarction?. Drug Discovery Today. 28(10). 103695–103695.
6.
Hussain, Md Sadique, Obaid Afzal, Gaurav Gupta, et al.. (2023). Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling. Pathology - Research and Practice. 249. 154738–154738.
7.
Kalaskar, Mohan, Kalpesh R. Patil, Ajay Sharma, et al.. (2023). Volatile Oil Containing Plants as Phytopharmaceuticals to Treat Psoriasis:A Review. Current Pharmaceutical Biotechnology. 25(3). 313–339.
8.
Hussain, Afzal, Mohammad A. Altamimi, Obaid Afzal, et al.. (2023). Mechanistic of Vesicular Ethosomes and Elastic Liposomes on Permeation Profiles of Acyclovir across Artificial Membrane, Human Cultured EpiDerm, and Rat Skin: In Vitro-Ex Vivo Study. Pharmaceutics. 15(9). 2189–2189.
9.
Shaikh, Mohammad Arshad Javed, Obaid Afzal, Waleed Hassan Almalki, et al.. (2023). Harnessing chitosan-adorned liposomes for enhanced drug delivery in cancer. Journal of Drug Delivery Science and Technology. 85. 104619–104619.
10.
Ullah, Shehla Nasar Mir Najib, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.. (2023). Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art. Biomedicines. 11(6). 1752–1752.
11.
Alamri, Mubarak A., Obaid Afzal, Md Jawaid Akhtar, et al.. (2023). Synthesis, in silico and in vitro studies of novel quinazolinone derivatives as potential SARS-CoV-2 3CLpro inhibitors. Arabian Journal of Chemistry. 17(1). 105384–105384.
12.
Mandal, Ashok Kumar, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, et al.. (2023). Emergence of Nano-Based Formulations for Effective Delivery of Flavonoids against Topical Infectious Disorders. Gels. 9(8). 671–671.
13.
Afzal, Obaid, Mubarak A. Alamri, Ali Altharawi, et al.. (2023). Resveratrol-Loaded Chia Seed Oil-Based Nanogel as an Anti-Inflammatory in Adjuvant-Induced Arthritis. Gels. 9(2). 131–131.
14.
Sharma, Hemant, Abdulmalik Saleh Alfawaz Altamimi, Mubarak A. Alamri, et al.. (2022). Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study. Molecules. 27(4). 1159–1159.
15.
Gupta, Kartikey Kumar, Nitin Bhardwaj, Najla Altwaijry, et al.. (2022). The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway. Frontiers in Oncology. 12. 950835–950835.
16.
Alharbi, Khalid Saad, Obaid Afzal, Waleed Hassan Almalki, et al.. (2022). Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases. Chemico-Biological Interactions. 354. 109842–109842.
17.
Afzal, Obaid, et al.. (2021). Fabrication of Membrane Sensitive Electrodes for the Validated Electrochemical Quantification of Anti-Osteoporotic Drug Residues in Pharmaceutical Industrial Wastewater. Molecules. 26(16). 5093–5093.
18.
Alamri, Mubarak A., et al.. (2020). Computational screening of natural and natural-like compounds to identify novel ligands for sigma-2 receptor. SAR and QSAR in environmental research. 31(11). 837–856.
19.
Shiroorkar, Predeepkumar Narayanappa, Obaid Afzal, Imran Kazmi, et al.. (2020). Cardioprotective Effect of Tangeretin by Inhibiting PTEN/AKT/mTOR Axis in Experimental Sepsis-Induced Myocardial Dysfunction. Molecules. 25(23). 5622–5622.
20.
Kumar, Suresh, et al.. (2017). In-Vitro Antibacterial / Antifungal Screening of 2-Chloroquinoline Scaffold Derivatives. 1(1).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Abdulmalik Saleh Alfawaz Altamimi Breakdown of academic impact, for papers by V.G.M. Naidu Breakdown of academic impact, for papers by Chung Yeng Looi Breakdown of academic impact, for papers by Keshav Raj Paudel Breakdown of academic impact, for papers by Kulbhushan Tikoo Breakdown of academic impact, for papers by Tânia Beatriz Creczynski‐Pasa Breakdown of academic impact, for papers by Imran Kazmi Breakdown of academic impact, for papers by Sami I. Alzarea Breakdown of academic impact, for papers by István Zupkó Breakdown of academic impact, for papers by Saikat Dewanjee